Trial Details
COMPLETEDBasic Information
| Clinical ID | c1786 |
|---|---|
| Identifier | NCT04492787 |
| Trial Title | Efficacy and Safety of Changkang Granule in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome with Diarrhea |
| Interventions | DRUG: Changkang Granule|DRUG: Changkang Placebo Granule |
Participant Information
| Sponsor | Tasly Pharmaceutical Group Co., Ltd |
|---|---|
| City | Beijing |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2020-07-06 |
|---|---|
| Primary Completion Date | 2022-04-21 |
| Completion Date | 2022-04-21 |